Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients

Author： Di Minno Matteo Nicola Dario  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.18, Iss.1, 2013-03, pp. : 9-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3816-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 2055-2069

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim   Schott Gisela  

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Antiarrhythmic drugs for atrial fibrillation

By Marinelli Alessandro   Capucci Alessandro  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1201-1215

Informa Healthcare

Access to resources Recommend Favorite

Relation of Low Vitamin D to Nonvalvular Persistent Atrial Fibrillation in Chinese Patients

By Chen Wei Ren   Liu Zhi Ying   Shi Yang   Yin Da Wei   Wang Hao   Sha Yuan   Chen Yun Dai  

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 2, 2014-03 ,pp. : 166-173

Blackwell Publishing

Access to resources Recommend Favorite